The smartest Australian stocks to buy with $400 right now

Let's see why these shares are highly rated by brokers.

| More on:
A woman wearing dark clothing and sporting a few tattoos and piercings holds a phone and a takeaway coffee cup as she strolls under the Sydney Harbour Bridge which looms in the background.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

You don't need thousands of dollars to start investing in the share market. Even a modest sum like $400 can get you on the path to building wealth — as long as you choose quality companies with strong long-term growth potential.

If you're ready to put that $400 to work today, here are three Australian stocks that analysts think could make a smart starting point for a beginner or someone looking to top up their portfolio. They are as follows:

Life360 Inc. (ASX: 360)

For investors looking for strong growth, Life360 could be an Australian stock to buy. Best known for its family safety app, Life360 now boasts 83.7 million monthly active users and is generating huge revenue from them. In fact, revenue climbed 32% year over year in the March quarter to US$103.6 million.

The company has turned the corner on profitability, generating positive operating cash flow and growing its paid users at a rapid pace. With new features and monetisation opportunities on the horizon, Life360 could be a stock with multi-year upside.

Morgan Stanley thinks it could be a buy and has an overweight rating and $40.00 price target on its shares.

ResMed Inc. (ASX: RMD)

Another Australian stock that could be a buy is ResMed. It is the global leader in sleep apnoea and respiratory care devices.

This is a huge market to be in, with over 1 billion people estimated to suffer from sleep apnoea globally. And with the vast majority of these sufferers unaware of their condition, ResMed stands to benefit greatly as knowledge increases. The latter is being helped by devices like the Apple Watch, which is now able to diagnose sleep apnoea.

So, with a growth outlook stretching into the decades and a valuation that looks cheap compared to historical multiples, now could be a great time to invest.

The team at Macquarie certainly believes this is the case. The broker has an outperform rating and $48.00 price target on its shares.

Telstra Group Ltd (ASX: TLS)

A final Australian stock to consider buying with the $400 is telco giant Telstra.

Its outlook has become increasingly positive this year thanks to its new Connected Future 30 strategy which aims to expand its return on invested capital to 10% by FY 2030, alongside steady dividend growth and potential buybacks.

This new strategy went down well with analysts at Macquarie. So much so, it recently put an outperform rating and $5.28 price target on its shares.

Motley Fool contributor James Mickleboro has positions in Life360 and ResMed. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Life360, Macquarie Group, and ResMed. The Motley Fool Australia has positions in and has recommended Macquarie Group, ResMed, and Telstra Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Man putting in a coin in a coin jar with piles of coins next to it.
Broker Notes

Two ASX penny stocks Bell Potter thinks are worth watching in 2026

Bell Potter is tipping upside on these penny stocks.

Read more »

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to buy these shares.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Broker Notes

Why Bell Potter just upgraded this ASX All Ords share to a buy rating

The broker has turned bullish on this growing company. Here's what you need to know.

Read more »

A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate
Broker Notes

Bell Potter says these ASX shares are best buys in January

The broker has good things to say about these shares.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A group of people push and shove through the doors of a store, trying to beat the crowd.
Broker Notes

2 ASX shares highly recommended to buy: Experts

Are these two stocks the best buys on the ASX?

Read more »

Smiling couple sitting on a couch with laptops fist pump each other.
Broker Notes

These ASX 200 shares could rise 20% to 55%

Brokers have good things to say about these shares.

Read more »

A little girl is about to launch down the slide with a blue sky and white clouds in the sky behind her.
Broker Notes

BHP vs. Fortescue shares: Goldman Sachs says 1 will rip and 1 will dip

Top broker Goldman Sachs upgraded its 12-month share price forecasts for BHP and Fortescue shares this week.

Read more »